Photosensitizing action of isomeric zinc N-methylpyridylporphyrins in human carcinoma cells

References

• Detty MR, Gibson SL, Wagner SJ. Current clinical and preclinical photosensitizers for use in photodynamic therapy. J Med Chem 2004; 47: 3897–3915
   PubMed Web of Science ®Google Scholar
• Huang Z. A review of progress in clinical photodynamic therapy. Technol Cancer Res Treat 2005; 4: 283–293
   PubMed Web of Science ®Google Scholar
• Agostinis P, Buytaert E, Breyssens H, Hendrickx N. Regulatory pathways in photodynamic therapy induced apoptosis. Photochem Photobiol Sci 2004; 3: 721–729
   PubMed Web of Science ®Google Scholar
• Kriska T, Korytowski W, Girotti AW. Hyperresistance to photosensitized lipid peroxidation and apoptotic killing in 5-aminolevulinate-treated tumor cells overexpressing mitochondrial GPX4. Free Radic Biol Med 2002; 33: 1389–1402
   PubMed Web of Science ®Google Scholar
• Nyman ES, Hynninen PH. Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy. J Photochem Photobiol B 2004; 73: 1–28
   PubMed Web of Science ®Google Scholar
• Bellnier DA, Young DN, Detty MR, Camacho SH, Oseroff AR. pH-dependent chalcogenopyrylium dyes as potential sensitizers for photodynamic therapy: Selective retention in tumors by exploiting pH differences between tumor and normal tissue. Photochem Photobiol 1999; 70: 630–636
   PubMedGoogle Scholar
• Piette J, Volanti C, Vantieghem A, Matroule JY, Habraken Y, Agostinis P. Cell death and growth arrest in response to photodynamic therapy with membrane bound photosensitizers. Biochem Pharmacol 2003; 66: 1651–1659
   PubMed Web of Science ®Google Scholar
• Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. Photodynamic therapy. J Natl Cancer Inst 1998; 90: 889–905
   PubMed Web of Science ®Google Scholar
• Husain D, Miller JW, Kenney AG, Michaud N, Flotte TJ, Gragoudas ES. Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative. Ophthalmology 1997; 104: 1242–1250
   PubMed Web of Science ®Google Scholar
• Colussi VC, Feyes DK, Mukhtar H. Perspectives of photodynamic therapy for skin diseases. Skin Pharmacol Appl Skin Physiol 1998; 11: 336–346
   PubMedGoogle Scholar
• Woodburn KW, Fan Q, Kessel D, Wright M, Mody TD, Hemmi G, Magda D, Sessler JL, Dow WC, Miller RA, Young SW. Phototherapy of cancer and atheromatous plaque with texaphyrins. J Clin Laser Med Surg 1996; 14: 343–348
   PubMedGoogle Scholar
• Smetana Z, Ben-Hur E, Mendelson E, Salzberg S, Wagner P, Malik Z. Herpes simplex virus proteins are damaged following photodynamic inactivation with phthalocyanines. J Photochem Photobiol B 1998; 44: 77–83
   PubMedGoogle Scholar
• Ben-Hur E, Oetjen J, Horowitz B. Silicon phthalocyanine Pc 4 and red light causes apoptosis in HIV-infected cells. Photochem Photobiol 1997; 65: 456–460
   PubMedGoogle Scholar
• Georgiou GN, Ahmet MT, Houlton A, Silver J, Cherry RJ. Measurement of the rate of uptake and subcellular localization of porphyrins in cells using fluorescence digital imaging microscopy. Photochem Photobiol 1994; 59: 419–422
   PubMedGoogle Scholar
• Villanueva A, Jori G. Pharmacokinetic and tumour-photosensitizing properties of the cationic porphyrin meso-tetra(4N-methylpyridyl)porphine. Cancer Lett 1993; 73: 59–64
   PubMedGoogle Scholar
• Benov L, Batinic-Haberle I, Spasojevic I, Fridovich I. Isomeric N-alkylpyridylporphyrins and their Zn(II) complexes: Inactive as SOD mimics but powerful photosensitizers. Arch Biochem Biophys 2002; 402: 159–165
   PubMed Web of Science ®Google Scholar
• Li QY, Pedersen C, Day BJ, Patel M. Dependence of excitotoxic neurodegeneration on mitochondrial aconitase inactivation. J Neurochem 2001; 78: 746–755
   PubMed Web of Science ®Google Scholar
• Ceckler TL, Bryant RG, Penney DP, Gibson SL, Hilf R. 31P-NMR spectroscopy demonstrates decreased ATP levels in vivo as an early response to photodynamic therapy. Biochem Biophys Res Commun 1986; 140: 273–279
   PubMedGoogle Scholar
• Kalyanasundaram K. Photochemistry of water-soluble porphyrins: Comparative study of isomeric tetrapyridyl- and tetrakis (N-methylpyridiniumyl) porphyrins. Inorg Chem 1983; 23: 2453–2459
   Google Scholar
• Boyle RW, Dolphin D. Structure and biodistribution relationships of photodynamic sensitizers. Photochem Photobiol 1996; 64: 469–485
   PubMed Web of Science ®Google Scholar
• Kinsey JH, Cortese DA, Moses HL, Ryan RJ, Branum EL. Photodynamic effect of hematoporphyrin derivative as a function of optical spectrum and incident energy density. Cancer Res 1981; 41: 5020–5026
   PubMed Web of Science ®Google Scholar
• Cubeddu R, Canti G, Musolino M, Pifferi A, Taroni P, Valentini G. Absorption spectrum of hematoporphyrin derivative in vivo in a murine tumor model. Photochem Photobiol 1994; 60: 582–585
   PubMedGoogle Scholar
• Romanova NA, Pometun EV, Brovko LY, Ugarova NN, Savitsky AP. Bioluminescent assay of ATP leakage from yeast cells after photodynamic damage. Proceedings of the 11th International Symposium on Bioluminescence and Chemiluminescence, PJ Case JF. Herring, BH Robison, SHD Haddock, LJ Kricka, PE Stanley. World Scientific, London, England 2000; 305–308
   Google Scholar
• Hazama A, Fan HT, Abdullaev I, Maeno E, Tanaka S, Ando-Akatsuka Y, Okada Y. Swelling-activated, cystic fibrosis transmembrane conductance regulator-augmented ATP release and Cl- conductances in murine C127 cells. J Physiol 2000; 523: 1–11
   PubMed Web of Science ®Google Scholar
• Sabirov RZ, Dutta AK, Okada Y. Volume-dependent ATP-conductive large conductance anion channel as a pathway for swelling-induced ATP release. J General Physiol 2001; 118: 251–266
   PubMedGoogle Scholar
• Dutta AK, Sabirov RZ, Uramoto H, Okada Y. Role of ATP-conductive anion channel in ATP release from neonatal rat cardiomyocytes in ischaemic or hypoxic conditions. J Physiol 2004; 559: 799–812
   PubMedGoogle Scholar